ArticleBiomedical optics express2025
Design of a polarization-insensitive terahertz metamaterial biosensor for glioma tissue identification.
Article in Biomedical optics express, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
There is an urgent need to develop label-free, accurate detection techniques for gliomas due to the high aggressiveness and heterogeneity of glioma tissues. In this study, a polarization-insensitive terahertz metamaterial biosensor based on a quadruple rotationally symmetric superunit is proposed to address the issues of insufficient sensitivity and polarization-dependent interference associated with conventional metamaterials in terahertz spectroscopy. The structural parameters were optimized through theoretical modeling and electromagnetic simulations, leading to the design of C4-symmetric metamaterials with stable responses over a wide incidence angle range. These metamaterials effectively mitigate signal distortion caused by the random orientation of metamaterial placement during experiments. The experiments were conducted using a terahertz frequency-domain spectroscopy system (THz-FDS) to detect isolated glioma tissues. The results demonstrate that the sensor maintains polarization insensitivity across the full 0-360° range, significantly enhancing the contrast in dielectric properties between tumor and normal tissues. Furthermore, its resonance frequency shift exhibits a strong correlation with tissue thickness, increasing up to 26 µm, after which it stabilizes and no longer exhibits significant changes. This study confirms that polarization-insensitive metamaterials can overcome existing imaging limitations, reduce operator-induced human errors, and provide a novel, non-invasive detection solution for intraoperative boundary delineation and pathological diagnosis of gliomas, with strong potential for clinical translation.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.